Top member reports
Company Report
Last edited one year ago
PerformanceCommunity EngagementCommunity Endorsement
Performance (34m)
-15.8% pa
Followed by
11
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#ASX Announcements
stale
Added one year ago

CHILDREN TREATED WITH REMESTEMCEL-L SHOW LONG-TERM SURVIVAL THROUGH FOUR YEARS IN STEROID-REFRACTORY ACUTE GRAFT VERSUS HOST DISEASE (SR-aGVHD)

https://ecomms.linkgroup.com/images/Link/62093/Long-Term%20Survival%20for%20Acute%20GvHD%20Treatment%20with%20Remestemcel.pdf

The BLA Resubmission is expected before the end of 2022 . Next year will be either a great year for MSB or another year of smoke and mirrors by SI.


abf022eb76010bb2f9f75a8554de5061140fcf.png